Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Arrowhead Pharmaceuticals, Inc. (ARWR)

Abivax SA Sponsored ADR and Arrowhead Pharmaceuticals, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. is the larger, with a market value of $8.1B against $7.4B — 1.1× the size. Abivax SA Sponsored ADR has the higher net margin (0.00% vs −47.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 7 and Abivax SA Sponsored ADR on 6.

Valuation

Metric ABVX ARWR Biotechnology median
P/E n/m n/m 10.26
P/S n/m 12.34 9.18
P/B 15.83 17.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 11.24 8.98
Earnings yield (7.16%) (3.90%) (34.89%)
Free cash flow yield (3.35%) (0.91%) (24.52%)

Profitability

Metric ABVX ARWR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (33.82%) 0.00%
Net margin 0.00% (47.79%) 0.00%
Free cash flow margin 0.00% (11.22%) 0.00%
Return on equity (249.78%) (64.91%) (50.12%)
Return on assets (137.67%) (18.32%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABVX ARWR Biotechnology median
Revenue growth (TTM) — 16.13% 6.26%
EPS growth (last fiscal year) (80.20%) 99.80% 29.88%
Revenue growth, 5-year CAGR — 56.63% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX ARWR Biotechnology median
Debt to equity 0.00 1.85 0.00
Current ratio 5.97 5.90 4.89
Net debt to EBITDA 2.19 (5.70) 1.01

Dividend

Metric ABVX ARWR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABVX ARWR Biotechnology median
Market cap 7.37b 8.12b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack